CD55 anticorps
-
- Antigène Voir toutes CD55 Anticorps
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp CD55 est non-conjugé
-
Application
- Flow Cytometry (FACS)
- Fonction
- CD55 Unconjugated Antibody
- Attributs du produit
- The clone F4-29D9 binds with a single chain 70 kDa glycoprotein and identified as CD55 (also known as decay accelerating factor, DAF). CD55 is widely expressed on cells throughout the body including leukocytes, erythrocytes, epithelium, endothelium, and fibroblasts. It is a Glycosyl phosphatidylinositol anchored (GPI-anchored) protein and inhibits autologous complement cascade activation. CD55 also serves as receptor for CD97, echovirus and Coxsackie B virus. Anticd55 is a useful marker for the diagnosis of paroxysmal nocturnal hemoglobinuria (PNH).
- Purification
- Purified
- Pureté
- >95 %
- Classe de qualité
- GMP Grade
- Immunogène
- Human umbilical vein endothelial cells (HUVEC)
- Clone
- F4-29D9
- Isotype
- IgG1, kappa
- Top Product
- Discover our top product CD55 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- PBS pH 7.2, 0.1 % (w/v) BSA, 0.09 % (w/v) sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C
-
- Antigène
- CD55 (Complement Decay-Accelerating Factor (CD55))
- Autre désignation
- CD55 (CD55 Produits)
- Synonymes
- anticorps CR, anticorps CROM, anticorps DAF, anticorps TC, anticorps Daf, anticorps Daf-GPI, anticorps Daf1, anticorps GPI-DAF, anticorps CD55 molecule (Cromer blood group), anticorps CD55 molecule, decay accelerating factor for complement, anticorps CD55, anticorps Cd55
- NCBI Accession
- NP_000565, NM_000574, NP_001108224, NM_001114752, NP_001287832, NM_001300903, NP_001287833
- UniProt
- P08174
- Pathways
- Système du Complément, Regulation of Leukocyte Mediated Immunity
-